Bristol-Myers Squibb receives European Commission approval for Opdivo Hodgkin lymphoma drug
Bristol-Myers Squibb receives European Commission approval for Opdivo Hodgkin lymphoma drug
About this item
Full title
Bristol-Myers Squibb receives European Commission approval for Opdivo Hodgkin lymphoma drug
Publisher
London: Normans Media Ltd
Journal title
M2 Pharma, 2016
Language
English
Formats
Publication information
Publisher
London: Normans Media Ltd
Subjects
More information
Scope and Contents
Contents
M2PHARMA-November 24, 2016-Bristol-Myers Squibb receives European Commission approval for Opdivo Hodgkin lymphoma drug (C)2016 M2 COMMUNICATIONS http://www.m2.com Bristol-Myers Squibb, a global biopharmaceutical company, has received approval from the European Commission for Opdivo, it was reported ye...
Alternative Titles
Full title
Bristol-Myers Squibb receives European Commission approval for Opdivo Hodgkin lymphoma drug
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1842860115
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1842860115
How to access this item
Log in as a Library member
